Rockstar @inovaheart CHIP/SHOCK coordinator Carolyn Rosner discussing role of hemodynamics and MCS in patients undergoing eval for HRPCI. Christopher O'Connor Charles Murphy, MD Shashank Sinha, MD, MSc, FACC, FAHA Robert Cole Mitchell Psotka
High risk RCA lesion with severe ca++ between 2 bends, has to go femoral with RV pacing, 1.5 mm burr followed by guidezella for support to deliver stent/balloons, pt was surgical turn down for severe lung disease & low DLCO.
#CHIP #Atherectomy #HRPCI
Ryan P. Daly, MD theMDwriter, Louis Janeira, MD
Congratulations Mohammed Israil on enrolling their first cases for SAFE-MCS. A trial evaluating the role of early bleeding detection in HRPCI requiring MCS. Congratulations to Dr Fuller Mohammad Zaidan MD Alejandro Lemor MD, MS Philippe Genereux Amir Kaki, MD
Dr Marc Feldman, University Hosptial, SA Academic Leader & Dr Balderas HRPCI - 99% LIMA-LAD. Circ/RCA 100% collaterals from LAD. Old stent LAD occluded. Multiple inflation to old stent, new stent overlapping. Impella permitted time needed for the job. Seth Bilazarian, MD Jamil Malik
Join us at 12 pm CST for a Case-based Approach to Revascularization Challenges Mitul P. Patel Amir Kaki, MD Sahil A. Parikh, MD Nadia Sutton Poonam Velagapudi Jacqueline Saw American College of Cardiology #ACC23 #MCS #HRPCI #SCAD
Our analysis of patients with chronic kidney disease (first report of dialysis pts) who received Impella assisted HRPCI in Protect III CircInterventions #CirculationIntv #MedTwitter #CardioTwitter
💥Lower eGFR had more severely calcified CAD, greater atherectomy usage but no increased…
Learning from the great Amir Kaki, MD ! Awesome presentation in Sarasota, FL on improving cardiogenic shock outcomes and HRPCI w Impella.
